These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 6243667

  • 1. Effects of physiological infusion of epinephrine in normal humans: relationship between the metabolic response and beta-adrenergic binding.
    Soman VR, Shamoon H, Sherwin RS.
    J Clin Endocrinol Metab; 1980 Feb; 50(2):294-7. PubMed ID: 6243667
    [Abstract] [Full Text] [Related]

  • 2. Important role of adrenergic mechanisms in acute glucose counterregulation following insulin-induced hypoglycemia in type I diabetes. Evidence for an effect mediated by beta-adrenoreceptors.
    Bolli G, de Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P.
    Diabetes; 1982 Jul; 31(7):641-7. PubMed ID: 6298039
    [Abstract] [Full Text] [Related]

  • 3. Metabolic effects of prostaglandin E2 infusion in man: possible adrenergic mediation.
    Newman WP, Brodows RG.
    J Clin Endocrinol Metab; 1982 Sep; 55(3):496-501. PubMed ID: 7047549
    [Abstract] [Full Text] [Related]

  • 4. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
    Rizza RA, Cryer PE, Haymond MW, Gerich JE.
    J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
    [Abstract] [Full Text] [Related]

  • 5. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.
    Kraenzlin ME, Keller U, Keller A, Thélin A, Arnaud MJ, Stauffacher W.
    J Clin Invest; 1989 Aug; 84(2):388-93. PubMed ID: 2569473
    [Abstract] [Full Text] [Related]

  • 6. Altered glucoregulatory response to physiological infusions of epinephrine and glucagon in hyperthyroidism.
    Perez G, Ungaro B, Covelli A, Morrone G, Lombardi G, Scopacasa F, Rossi R.
    J Clin Endocrinol Metab; 1980 Nov; 51(5):972-7. PubMed ID: 7419694
    [Abstract] [Full Text] [Related]

  • 7. Regulation of glucose turnover during exercise in pancreatectomized, totally insulin-deficient dogs. Effects of beta-adrenergic blockade.
    Bjorkman O, Miles P, Wasserman D, Lickley L, Vranic M.
    J Clin Invest; 1988 Jun; 81(6):1759-67. PubMed ID: 3290252
    [Abstract] [Full Text] [Related]

  • 8. Interaction of free fatty acids and epinephrine in regulating hepatic glucose production in conscious dogs.
    Chu CA, Galassetti P, Igawa K, Sindelar DK, Neal DW, Burish M, Cherrington AD.
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E291-301. PubMed ID: 12531743
    [Abstract] [Full Text] [Related]

  • 9. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L, Sherwin R, Hendler R, Felig P.
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [Abstract] [Full Text] [Related]

  • 10. Adrenergic effects on plasma levels of glucagon, insulin, glucose and free fatty acids in rabbits.
    Knudtzon J.
    Horm Metab Res; 1984 Aug; 16(8):415-22. PubMed ID: 6381275
    [Abstract] [Full Text] [Related]

  • 11. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
    Giugliano D, Cozzolino D, Salvatore T, Torella R, Franchimont P, D'Onofrio F, Lefebvre PJ.
    J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
    [Abstract] [Full Text] [Related]

  • 12. Effect of protein-supplemented fasting on metabolic and hormonal responses to epinephrine infusion in obese subjects.
    Scheen A, Cession-Fossion A, Scheen-Lavigne M, Luyckx A.
    Horm Metab Res; 1982 May; 14(5):240-5. PubMed ID: 7047346
    [Abstract] [Full Text] [Related]

  • 13. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs.
    el-Tayeb KM, Vranic M, Brubaker PL, Lickley HL.
    Diabetologia; 1987 Sep; 30(9):745-54. PubMed ID: 2962893
    [Abstract] [Full Text] [Related]

  • 14. Adrenergic modulation of human pancreatic polypeptide (hPP) release.
    Sive AA, Vinik AI, Levitt N.
    Gastroenterology; 1980 Oct; 79(4):665-72. PubMed ID: 6997131
    [Abstract] [Full Text] [Related]

  • 15. Lack of beta-adrenergic role for catecholamines in the development of hyperglycemia and ketonaemia following acute insulin withdrawal in type I diabetic patients.
    Beylot M, Sautot G, Dechaud H, Cohen R, Riou JP, Serusclat P, Mornex R.
    Diabete Metab; 1985 Apr; 11(2):111-7. PubMed ID: 2989015
    [Abstract] [Full Text] [Related]

  • 16. Insulin and glucagon responses to adrenaline infusion in abdominal obese men.
    Mauriège P, Klein Kranenbarg WM, Prud'homme D, Lamarche B, Tremblay A, Bouchard C, Nadeau A, Després JP.
    Int J Obes Relat Metab Disord; 1996 Jul; 20(7):668-76. PubMed ID: 8817361
    [Abstract] [Full Text] [Related]

  • 17. Epinephrine-induced insulin resistance in man.
    Deibert DC, DeFronzo RA.
    J Clin Invest; 1980 Mar; 65(3):717-21. PubMed ID: 6243677
    [Abstract] [Full Text] [Related]

  • 18. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.
    Clutter WE, Bier DM, Shah SD, Cryer PE.
    J Clin Invest; 1980 Jul; 66(1):94-101. PubMed ID: 6995479
    [Abstract] [Full Text] [Related]

  • 19. Glucoregulatory role of cortisol and epinephrine interactions studied in adrenalectomized dogs.
    Gauthier C, el-Tayeb K, Vranic M, Lickley HL.
    Am J Physiol; 1986 Apr; 250(4 Pt 1):E393-401. PubMed ID: 3515964
    [Abstract] [Full Text] [Related]

  • 20. Role of glucagon in mediating metabolic effects of epinephrine.
    Chideckel EW, Goodner CJ, Koerker DJ, Johnson DG, Ensinck JW.
    Am J Physiol; 1977 May; 232(5):E464-70. PubMed ID: 404888
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.